SEC Form D · Amendment · filed April 1, 2019
Checkmate Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Barry Labinger · Cambridge, MAExec · DirectorCharles M. Yon · Cambridge, MAExecMichael J. Powell · Billerica, MADirectorArt Krieg · Cambridge, MAExec · DirectorDavid M. Mauro · Cambridge, MAExecChuck Abdalian · Cambridge, MAExecKaren Brennan · Cambridge, MAExecBen M. Auspitz · Cambridge, MADirectorCorey M. Goodman · Cambridge, MADirectorDonald P. Martin · Reston, VAExecRick L. Ryan · St. Louis, MOExecBrendan Keating · Las Vegas, NVExec · DirectorJames Sinclair · Ithaca, X1ExecClifford K. Holekamp · St. Louis, MODirectorMichele White · Windsor, CTExec · DirectorDavid A. Smoller · St. Louis, MODirectorC. R. Mullet · Reston, VADirectorTimothy Murphy · Des Moines, IAExecArthur Reidel · San Martin, CADirectorGerald Fitch · Newport Coast, CAExecAhmad Atwan · New York, NYDirectorAndrew Medvedev · New York, NYDirectorJames Wilmott · New York, NYExecThomas B. Doran · Minneapolis, MNExecStella Z. Xu, Ph.D · Solana Beach, CAExec · DirectorSimeon Z. George, M.D · Solana Beach, CAExecPaul L. Hoffmann · Monona, WIExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗